Laureate Education, Inc. (LAUR) · Oct 29, 2026 · Earnings

Laureate earnings beat estimates, but calendar timing boosts EBITDA

Beat — Adjusted EPS $0.52 vs ~$0.48 consensus; revenue $485.1M vs ~$480.2M

Laureate’s Q3 earnings beat revenue and adjusted EPS expectations, while enrollment growth stayed healthy and calendar timing inflated EBITDA.

Laureate is a focused higher-education operator in Mexico and Peru, using campus-based and online programs to expand enrollment—especially among working adults in Peru—while adding capacity such as its new Puebla campus. Its second-quarter update had already raised 2026 guidance on improving enrollment, revenue, EBITDA and EPS trends.

The quarter cleared a modestly raised bar. Adjusted EPS was $0.52 versus published consensus of roughly $0.48, while revenue was $485.1 million versus approximately $480.2 million. That is a genuine beat, but not a blowout: the revenue upside was only about 1%, and the comparison is against a market already expecting a sharp year-over-year rebound. Laureate said, “Basic and diluted earnings per share for the third quarter of 2026 were $0.74 and $0.73, respectively.”

MetricQ3 2026Q3 2025Consensus
Revenue (Financial Highlights)$485.1M (+21%)$400.2M~$480.2M
Adjusted EPS (Non-GAAP Reconciliations)$0.52$0.26~$0.48
Adjusted EBITDA (Financial Highlights)$146.8M (+55%)$94.8M
New enrollments (Enrollment table)281,800 (+9%)258,800
Total enrollments (Enrollment table)539,600 (+6%)511,400

Underlying demand is moving in the right direction. New enrollment rose 9% year to date, with Mexico up 8% and Peru up 10%; total enrollment increased 6%. That supports the company’s core growth story rather than making the quarter purely a currency or accounting event. Laureate said, “New enrollments for the nine months ended September 30, 2026 increased 9%.” 〔0〕

The headline EBITDA growth is partly a timing benefit, not all operating leverage. Reported revenue grew 21%, but constant-currency growth was 14%, and approximately $29 million of revenue and $26 million of adjusted EBITDA came from semester-start timing. That makes the operating result good, but less clean than the reported percentages suggest. Laureate explicitly said, “Adjusted EBITDA in the third quarter of 2026 was favorably affected by approximately $26million of intra-year academic calendar timing.”

Cash generation funded an aggressive capital-return program. Operating cash flow reached $324.6 million for the first nine months, while Laureate repurchased approximately $256 million of stock and ended the period with $189.9 million of cash against $202.7 million of debt. The buyback capacity is meaningful, but much of this capital-return direction was already visible from the July guidance update, so it adds less surprise than the earnings beat. Laureate said, “Laureate repurchased approximately $256million of its common stock during the nine months ended September 30, 2026.”

Bottom line: Laureate delivered a narrow earnings beat with real enrollment momentum, but the quarter’s exceptional EBITDA growth is partly pulled forward by academic-calendar timing. The business is advancing, though the clean underlying upside is smaller than the reported 55% EBITDA increase suggests.

What to watch next

Q4 report and full-year 2026 results, early 2027

Original filing on SEC EDGAR

Laureate earnings beat estimates, but calendar timing boosts EBITDA | LAUR Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.